Prebiotic approach alleviates hepatic steatosis: implication of fatty acid oxidative and cholesterol synthesis pathways.
about
Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomesIntestinal permeability--a new target for disease prevention and therapyEffects of orange juice formulation on prebiotic functionality using an in vitro colonic model systemSaccharomyces boulardii administration changes gut microbiota and reduces hepatic steatosis, low-grade inflammation, and fat mass in obese and type 2 diabetic db/db mice.Fructo-oligosaccharides and intestinal barrier function in a methionine-choline-deficient mouse model of nonalcoholic steatohepatitis.Microbiota-liver axis in hepatic disease.Acarbose, lente carbohydrate, and prebiotics promote metabolic health and longevity by stimulating intestinal production of GLP-1.Nutrition, nonalcoholic fatty liver disease and the microbiome: recent progress in the field.Meta-omic platforms to assist in the understanding of NAFLD gut microbiota alterations: tools and applications.Choline and Fructooligosaccharide: Non-alcoholic Fatty Liver Disease, Cardiac Fat Deposition, and Oxidative Stress Markers.Gut-liver axis, nutrition, and non-alcoholic fatty liver diseaseProtective effect of agaro-oligosaccharides on gut dysbiosis and colon tumorigenesis in high-fat diet-fed mice.Effect of prebiotics of Agave salmiana fed to healthy Wistar rats.Increasing whole grain intake as part of prevention and treatment of nonalcoholic Fatty liver disease.Therapeutic spectrum of nondigestible oligosaccharides: overview of current state and prospect.Fructo-oligosaccharide effects on serum cholesterol levels. An overview.Targeting the gut microbiota with inulin-type fructans: preclinical demonstration of a novel approach in the management of endothelial dysfunction.Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet.Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury.Gut Microbiota: Association with NAFLD and Metabolic Disturbances.Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphilaMediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease.Prebiotics supplementation improves the endothelial dysfunction in n-3 PUFA-depleted ApoE-/- mice.Calcitonin gene-related peptide: neuroendocrine communication between the pancreas, gut, and brain in regulation of blood glucose.Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy.Betaine supplementation causes increase in carnitine metabolites in the muscle and liver of mice fed a high-fat diet as studied by nontargeted LC-MS metabolomics approach.Implication of trans-11,trans-13 conjugated linoleic acid in the development of hepatic steatosis.Dual function of Lactobacillus kefiri DH5 in preventing high-fat-diet-induced obesity: direct reduction of cholesterol and upregulation of PPAR-α in adipose tissue.High Fructose Intake During Pregnancy in Rats Influences the Maternal Microbiome and Gut Development in the Offspring.
P2860
Q26778095-BAC1BAA5-216E-4E09-A396-EF6644157017Q27015884-DC8291F2-0996-4DB7-87C2-18F1CC08DE19Q30632064-09C5E962-338A-4F2D-AE8F-E8A23DAC620BQ33751828-4162AAD3-2FC5-43EC-9B78-7DAA195E4510Q33817253-749B1F1B-7B9D-4902-B540-7F8FADF867C1Q33855414-2F28B715-2ED3-46CE-BC74-88C317245056Q35047406-93BFDAD2-DFB0-44F0-AA03-BD6747578D87Q35074953-5C574356-BED5-4458-B3DA-CDE1072E400BQ35084719-5723403C-56FB-4FF0-8924-3E99A11B9875Q35586085-DB76D6C8-E859-4C49-84D4-F3A027D82328Q35685083-D2D9FF3D-EA06-4006-8F7E-366D0B6A11ACQ35894452-E149F77F-DFD1-4CE0-A5E1-F78BACA66458Q35995089-04CDB25F-2A65-4634-8DCA-9390C50FEC4DQ36896377-CACBA3D2-1302-444D-8930-165F34CFBB9BQ38232456-C8AB5BDF-F4BE-443B-88BF-0082C67234BCQ38504501-7182EEBC-B286-4A68-A3DD-00E92E779F9DQ38854649-40263E24-EC78-4B98-9EF8-970B5F8E3CF4Q39180593-A9ED2D57-22D4-4841-9BFF-975386EE0B7AQ40229016-84AE1D3A-FA64-42D7-BA2E-ECE716F612B4Q41564230-A660EDC1-87DB-47A1-8539-56A3286EB652Q41987488-6A1C91AE-6B20-43E7-96E2-65A8302EE869Q44339679-B299E04E-0D41-4484-82EA-7CF4767AB5AFQ45802046-A529893A-C2F2-4EBB-BEA9-4DEAEBBA5D07Q47112197-985FAF1F-BA20-4EB1-8355-35D24CC8CABEQ47116789-0E9EC9D2-9402-4E6B-BF5D-653519B019A3Q47979878-D04C9189-6B1A-494F-A6BB-D73E562D629EQ49490030-0F543EC1-9CFE-4607-9CC1-719C8C818A34Q51193316-8EDA9E49-8AD9-4F01-ABBA-C8EEBEC10AD3Q55511996-7FA31E25-A9CF-4912-8C0E-37A4B71377D9
P2860
Prebiotic approach alleviates hepatic steatosis: implication of fatty acid oxidative and cholesterol synthesis pathways.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Prebiotic approach alleviates ...... holesterol synthesis pathways.
@en
type
label
Prebiotic approach alleviates ...... holesterol synthesis pathways.
@en
prefLabel
Prebiotic approach alleviates ...... holesterol synthesis pathways.
@en
P2093
P2860
P50
P356
P1476
Prebiotic approach alleviates ...... holesterol synthesis pathways.
@en
P2093
Ahmed Essaghir
Barbara D Pachikian
Emilie Catry
Evelyne M Dewulf
Florence M Sohet
Laure-Alix Clerbaux
Laurence Portois
Sam Possemiers
Yvon A Carpentier
P2860
P304
P356
10.1002/MNFR.201200364
P577
2012-12-02T00:00:00Z